Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020)

DELHI, India - Oct. 17, 2016 - PRLog -- The report entitled "Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020)", provides analysis of the global cancer diagnostics market and the US cancer diagnostics market, with detailed analysis of market size and growth, penetration and market share. The report also provides the analysis of the global and the US cancer market, by prevalence, new cases, deaths, type of cancers, etc.

The report also discusses about the different diagnostic test of lung cancer and breast cancer. The diagnostics test analyzed in the report are: MetaStat (Meta Test) (Breast Cancer Test), OncotypeDX (Breast Cancer Test), OncoCyte (Lung Cancer Test), Veracyte's Test (Lung Cancer Test) and Integrated Diagnostics, Inc. Test (Lung Cancer Test).

Country Coverage

North America (US)

Executive Summary

A disease caused by abnormal growth of cells in the body, is called Cancer. In this disease, the formation of new cells slows or start dividing, forming lumps. However, all lumps are not cancerous; and this can be known by diagnosis.

There are various types of cancer- prostate cancer, breast cancer, lung and bronchus cancer, colon and rectum cancer, bladder cancer, melanoma of the skin, non-hodgkin lymphoma, kidney and renal, pelvis cancer, thyroid cancer, endometrial cancer and others.

Cancer is diagnosed using various tools, which confirm the presence of tumour, and the rate of its growth within the body. Cancer diagnosis can be segmented into: imaging testing, endoscopy, biopsy and tumour marker. Each segment can be sub segmented.

The global cancer diagnostic market is expected to increase at a significant growth rate during the forecasted period (2016-2020). The global cancer diagnostic market is supported by various growth drivers, such as the rising incidence of cancer, sedentary lifestyle, growing technological advancement, increasing awareness, etc.

List of Figures:

Figure 1: Cancer by Types

Figure 2: Cancer Diagnostic by Type of Tests

Figure 3: Global Cancer New Cases; 2012-2030 (Million)

Figure 4: Global Cancer Caused Deaths; 2012-2030 (Million)

Figure 5: US Cancer Prevalence; 2014-2015 (Million)

Figure 6: US Cancer Prevalence by Type; 2014

Figure 7: US Cancer New Cases and Death by Type; 2015 (Thousand)

Figure 8: Global Cancer Diagnostic Market by Value; 2011-2015 (US$ Billion)

Figure 9: Global Cancer Diagnostic Market by Value; 2016-2020 (US$ Billion)

Figure 10: Global Cancer Diagnostic Market by Type of Tests; 2015

Figure 11: Global Cancer Diagnostic Market by Type of Tests; 2020

Figure 12: Global Cancer Diagnostic Market by Type of Cancer; 2015

Figure 13: Global Cancer Diagnostic Market by Region; 2015

Figure 14: North America Cancer Diagnostic Market by Value; 2011-2015 (US$ Billion)

Figure 15: North America Cancer diagnostic Market by Value; 2016-2020 (US$ Billion)

Figure 16: Global Lung Cancer Diagnostic Market by Value; 2015-2020 (US$ Billion)

Figure 17: Global Lung Cancer Diagnostic Market by Type of Test; 2015

Figure 18: Global Lung Cancer Cases by Type

Figure 19:Global Breast Cancer Diagnostic Market by Value; 2015-2020 (US$ Billion)

Figure 20: Mena Beast Cancer Test Market Opportunity (US)

Figure 21: US Market Total Addressable Market (TAM)

Figure 22: US Mena Test Market by Number of Test and Addressable Population; 2017-2018

Figure 23:US Mena Test Market by Average reimbursement rate and Revenue; 2017-2018

Figure 24: OncotypeDX by Addressable Market

Figure 25: OncoCyte Test by Average Price and Revenue; 2017-2020

Figure 25: OncoCyte Test by Average Price and Revenue; 2017-2020

Figure 26: OncoCyte Test by Test Volume; 2017-2020

Figure 27: OncoCyte Test by Market Penetration; 2017-2020

Table 1: Global Cancer Prevalence, New cases and Death by Type; 2012

Table 2: US Mena Test Market Opportunity

For further details, kindly visit :

http://www.daedal-research.com//global-cancer-diagnostic-market-with-focus-on-lung-and-breast-cancer-2016-2020 (http://www.daedal-research.com/global-cancer-diagnostic-m...)

Rajeev Kumar

(Business Development Manager)

Address:  36 SFS Flats

Paschim Vihar

New Delhi-110063

Mobile: +91-9811715635

Tel: +91-120-4553017

Mail ID - info@daedal-research.com

Daedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. For more Information:

http://www.daedal-research.com